News
Patterson-UTI Energy Inc (NASDAQ:PTEN) is set to release its Q2 2025 earnings on Jul 24, 2025. The consensus estimate for Q2 ...
We recently published These 10 Stocks Fell Hard. Are You Holding Any? Patterson-UTI Energy, Inc. (NASDAQ:PTEN) is one of this ...
2d
Zacks Investment Research on MSNPatterson-UTI Energy Q2 Earnings Miss, Sales Beat Estimates, Fall Y/Y
Patterson-UTI Energy, Inc. PTEN reported a second-quarter 2025 adjusted net loss of 6 cents per share, which was wider than ...
2d
InvestorsHub on MSNPatterson-UTI Energy Shares Drop Nearly 3% Following Q2 Earnings Shortfall
On Thursday, Patterson-UTI Energy Inc. (NASDAQ:PTEN), a provider of drilling and completion services, reported a ...
CEO William Andrew Hendricks stated that “the second quarter saw several macro events take place that raised the volatility in the oil markets.” He highlighted that oil prices fluctuated between the ...
Ever since it was first identified more than 15 years ago, the PTEN gene has been known to play an integral role in preventing the onset and progression of numerous cancers. Now investigators ...
Patterson-UTI Energy PTEN reported a second-quarter 2022 adjusted net profit of 5 cents per share, beating the Zacks Consensus Estimate of a loss of 1 cent. This outperformance can be attributed ...
PTEN is a lipid and protein phosphatase. PTEN protein phosphatase can dephosphorylate protein substrates on serine, threonine and tyrosine residues (Myers et al., 1997). The lipid phosphatase ...
Inherited Pten mutations are rare, striking one in 200,000. If the research holds up, however, it could be important to larger numbers of cancer patients.
The tumor suppressor PTEN was originally identified as a negative regulator of the phosphoinositide 3-kinase (PI3K) signaling, a main regulator of cell growth, metabolism and survival. Yet this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results